Product NDC: | 50474-002 |
Proprietary Name: | Keppra |
Non Proprietary Name: | levetiracetam |
Active Ingredient(s): | 100 mg/mL & nbsp; levetiracetam |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50474-002 |
Labeler Name: | UCB, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021872 |
Marketing Category: | NDA |
Start Marketing Date: | 20060823 |
Package NDC: | 50474-002-63 |
Package Description: | 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) > 5 mL in 1 VIAL, SINGLE-USE |
NDC Code | 50474-002-63 |
Proprietary Name | Keppra |
Package Description | 10 VIAL, SINGLE-USE in 1 CARTON (50474-002-63) > 5 mL in 1 VIAL, SINGLE-USE |
Product NDC | 50474-002 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levetiracetam |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20060823 |
Marketing Category Name | NDA |
Labeler Name | UCB, Inc. |
Substance Name | LEVETIRACETAM |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |